Emisphere Technologies, Inc.

202 articles about Emisphere Technologies, Inc.

• Novo Nordisk Completes Acquisition of Emisphere Technologies for $1.35 Billion

  12/8/2020

  Emisphere Technologies, Inc. announced the completion of the previously announced transaction whereby Novo Nordisk A/S acquired Emisphere, on a cash-free, debt-free basis, for $1.35 billion.

• 

  Novo Nordisk Acquires Emisphere Tech in $1.8 Billion Deal

  11/6/2020

  Denmark’s Novo Nordisk is acquiring New Jersey-based Emisphere Technologies in a deal worth about $1.8 billion. Novo Nordisk and Emisphere have been partnered since 2007.

• Emisphere Transitions To Non-Reporting Public Company

  8/14/2017

• Emisphere Reports First Quarter 2017 Financial Results

  5/12/2017

• Emisphere Announces First Quarter 2017 Earnings Conference Call

  5/3/2017

• Emisphere Reports Fourth Quarter And Full Year 2016 Financial Results

  3/29/2017

• Emisphere Announces Fourth Quarter And Full Year 2016 Earnings Conference Call

  3/21/2017

• Emisphere Restructures Debt Agreements, Providing Greater Stability For Business Growth And Expansion

  12/12/2016

• Emisphere Reports Third Quarter 2016 Financial Results

  11/14/2016

• Emisphere Announces Third Quarter 2016 Earnings Conference Call

  11/7/2016

• Emisphere Announces Second Quarter 2016 Earnings Conference Call

  8/9/2016

• Emisphere Reports Third Quarter 2015 Financial Results

  11/16/2015

• Emisphere To Present At SeeThruEquity MicroCap Investor Forum

  11/6/2015

• Emisphere, Novo Nordisk A/S Ink $221 Million+ Deal Develop Oral Formulations of Four Molecules Targeting Metabolic Indications

  10/15/2015

• Emisphere Technologies, Inc. To Present At Rodman & Renshaw 17th Annual Global Investment Conference

  9/3/2015

• Emisphere Technologies, Inc. Highlights Eligen Licensee Novo Nordisk A/S's Entry Into Phase IIIa Development Of Oral Semaglutide, A Once Daily Oral GLP-1

  8/26/2015

• Emisphere Technologies, Inc. Announces First Quarter 2015 Financial Results Conference Call

  5/11/2015

• Emisphere Technologies, Inc. Reports Fourth Quarter And Full Year 2014 Financial Results

  3/31/2015

• Emisphere Technologies, Inc. Announces Fourth Quarter and Full Year 2014 Financial Results Conference Call

  3/26/2015

• Emisphere Technologies, Inc. Launches Eligen B12, The First Oral Prescription Tablet Proven To Normalize B12 Levels Without The Need For An Injection

  3/19/2015